Task Force to Study Restructuring Maryland's Electric Utility Industry
HB0054 repeals the sunset on a 2022 law governing the Health Services Cost Review Commission’s user fee assessment authority. Under current law, the Commission may assess and collect user fees from hospitals and related institutions, but the total amount is capped by a formula tied to hospital revenue and the Commission’s budget. The bill keeps those fee limits in place while making the underlying authority permanent rather than expiring on June 30, 2025.
The measure also reenacts, without substantive change, the statutory provisions that define the facilities subject to the fees, require the fees to be deposited into the Health Services Cost Review Commission Fund, and restrict their use to the Commission’s statutory and administrative costs. In effect, the bill preserves the existing financing structure for the Commission and prevents a lapse in its ability to fund operations through user fees.
The bill amends Maryland Health-General § 19-213 and related uncodified provisions from Chapters 696 and 697 of the Acts of 2022 by removing the automatic termination date. As a result, the Health Services Cost Review Commission retains ongoing authority to assess user fees on regulated hospitals and related institutions, subject to the existing caps and spending restrictions. Hospitals and other covered facilities remain the parties directly affected by the fee assessment, while the Commission continues to rely on the fund for operational support.
The available record suggests the bill was routine and largely noncontroversial, with no recorded committee testimony or vote data indicating opposition. Because the bill simply extends an existing funding mechanism and preserves current limits, the general sentiment appears to have been practical and supportive, focused on avoiding an unintended expiration of the Commission’s fee authority.
No specific points of contention are reflected in the provided transcripts or voting history. The only likely policy issue is whether the Commission should continue to have permanent authority to assess user fees on hospitals and related institutions, but the bill does not change the fee cap or expand the fee base, which likely reduced controversy. Any concern would primarily come from affected hospitals and regulated facilities that pay the fees, while supporters would include the Commission and those favoring stable regulatory funding.